Zacks Research Issues Negative Outlook for A Earnings

Agilent Technologies, Inc. (NYSE:A) – Equities research analysts at Zacks Research decreased their Q2 2026 earnings per share estimates for shares of Agilent Technologies in a research report issued to clients and investors on Monday, February 24th. Zacks Research analyst R. Department now forecasts that the medical research company will earn $1.46 per share for the quarter, down from their prior estimate of $1.47. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.56 per share.

Other equities analysts have also issued research reports about the company. StockNews.com upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Robert W. Baird cut their price target on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday. Barclays upgraded Agilent Technologies from an “underweight” rating to an “equal weight” rating and raised their price objective for the stock from $135.00 to $145.00 in a research note on Monday, February 10th. Sanford C. Bernstein reduced their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a report on Tuesday, November 26th. Finally, Bank of America dropped their price target on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research note on Friday, December 13th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Price Performance

Shares of A opened at $127.83 on Thursday. The firm has a market capitalization of $36.47 billion, a PE ratio of 29.39, a PEG ratio of 3.64 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. The company’s 50-day moving average is $140.64 and its 200-day moving average is $139.14. Agilent Technologies has a fifty-two week low of $124.16 and a fifty-two week high of $155.35.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.58% and a net margin of 19.27%. The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion.

Hedge Funds Weigh In On Agilent Technologies

Several large investors have recently modified their holdings of A. CKW Financial Group increased its stake in shares of Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after buying an additional 100 shares during the period. Global X Japan Co. Ltd. increased its position in Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 116 shares during the period. Redwood Park Advisors LLC bought a new position in Agilent Technologies during the 4th quarter worth approximately $27,000. Lee Danner & Bass Inc. acquired a new position in shares of Agilent Technologies in the 4th quarter worth approximately $29,000. Finally, Sunbelt Securities Inc. boosted its stake in shares of Agilent Technologies by 640.0% in the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 192 shares during the last quarter.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares in the company, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Agilent Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 annualized dividend and a yield of 0.78%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s payout ratio is 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.